Press Releases

Danaher Corporation (NYSE: DHR) today announced results for the second quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations unless otherwise...

WASHINGTON, D.C., July 9, 2013 - Danaher Corporation (NYSE:DHR) announced that it will comment today on the Company's second quarter 2013 financial performance in a presentation at its Investor...

WASHINGTON, D.C., July 2, 2013 -- Danaher Corporation (NYSE:DHR) will host a live video webcast of its Investor and Analyst Meeting on July 9, 2013 beginning at 1:00 p.m. CDT and concluding at...

Washington, D.C., June 18, 2013 - Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2013 on Thursday, July 18, 2013...

Continuing its long history of proven clinical performance in diagnosis of myocardial infarction (MI), Beckman Coulter, Inc. announces the U.S. Food and Drug Administration (FDA) 510(k) clearance...